Skip to main content
Market icon

Casos de sarampo nos EUA até 30 de abril?

Market icon

Casos de sarampo nos EUA até 30 de abril?

Polymarket

$191,021 Vol.

Polymarket

$191,021 Vol.

1800

$48,601 Vol.

65%

1850

$5,330 Vol.

17%

1900

$50,792 Vol.

7%

1950

$20,403 Vol.

3%

2000

$42,683 Vol.

2%

2100

$7,273 Vol.

2%

2200

$15,939 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,714 confirmed measles cases in the United States this year, with 94% outbreak-associated across 17 new outbreaks in 33 jurisdictions, primarily fueled by declining MMR vaccination coverage—now at 92.5% among kindergarteners, below the 95% herd immunity threshold—and importations from global hotspots. Recent weekly gains of 43 cases underscore sustained transmission in under-vaccinated communities, though most outbreaks remain small and contained. Trader consensus reflects this trajectory amid inherent epidemiological uncertainty from potential new importations or containment successes. Watch for the next CDC weekly surveillance update, expected imminently, which could refine case counts before the April 30 resolution based on the official national total.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$191,021
Data de Término
30 abr 2026
Mercado Aberto
Apr 14, 2026, 9:30 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,714 confirmed measles cases in the United States this year, with 94% outbreak-associated across 17 new outbreaks in 33 jurisdictions, primarily fueled by declining MMR vaccination coverage—now at 92.5% among kindergarteners, below the 95% herd immunity threshold—and importations from global hotspots. Recent weekly gains of 43 cases underscore sustained transmission in under-vaccinated communities, though most outbreaks remain small and contained. Trader consensus reflects this trajectory amid inherent epidemiological uncertainty from potential new importations or containment successes. Watch for the next CDC weekly surveillance update, expected imminently, which could refine case counts before the April 30 resolution based on the official national total.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$191,021
Data de Término
30 abr 2026
Mercado Aberto
Apr 14, 2026, 9:30 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado com os links externos.

Frequently Asked Questions

"Casos de sarampo nos EUA até 30 de abril?" is a prediction market on Polymarket with 7 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "1800" at 65%, followed by "1850" at 17%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 65¢ implies that the market collectively assigns a 65% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Casos de sarampo nos EUA até 30 de abril?" has generated $191K in total trading volume since the market launched on Mar 24, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Casos de sarampo nos EUA até 30 de abril?," browse the 7 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Casos de sarampo nos EUA até 30 de abril?" is "1800" at 65%, meaning the market assigns a 65% chance to that outcome. The next closest outcome is "1850" at 17%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Casos de sarampo nos EUA até 30 de abril?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.